During the course of studying the antiplatelet aggregating effects of Indonesian medicinal plant extracts, we found that the Cassia alata leaf extract had strong inhibitory effects on platelet aggregation induced by collagen. 1) In the present study, we attempted to isolate a constituent(s) from the C. alata leaf extract, in which platelet aggregatory activity was evaluated with a platelet aggregometer using a laser-scattering method. The method was proven to be rapid and sensitive in detecting the antiplatelet aggregating activity, with additional data on the size distribution of platelet aggregates.
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Assay for Platelet Aggregation Activity Platelet aggregation was measured according to a particle counting method using light-scattering (PA-20, Kowa, Japan). [1] [2] [3] [4] Briefly, 300 ml of the platelet suspension as prepared above in a cuvette was mixed with 24 ml of adenine or adenosine diluted with saline (20 mM and 200 mM as final concentrations), where sonication and heat were provided to dissolve adenine in saline completely. Then, the reaction was initiated with stirring at 37°C after calibrating the optical density (OD) using PPP. After reacting for 1 min, 36 ml of 10.0 mg/ml collagen or 36 ml of 50.0 mM ADP as an aggregating agent was added to the mixture to monitor the platelet activating activity, where saline was used as a blank. The reaction was recorded for 7 min. The extent of inhibition of platelet aggregation was expressed by using the following equation: inhibition (%)ϭ(1ϪB/A)ϫ100
where A is OD in the presence of collagen or ADP as an aggregating agent and B is OD in the presence of adenine or adenosine dissolved in saline and collagen or ADP.
Isolation of Active Constituent After attempting various procedures to obtain the active constituent, the final isolation procedure was determined as follows: 100 g of sundried C. alata leaf was extracted twice with 1000 ml of 50% ethanol in a water bath at 80°C for 20 min. The extract was filtered and concentrated under reduced pressure. The yield was 35.30 g (paste to film). The crude extract, redissolved in about 100 ml of 50% MeOH, was further applied on a column packed with 1.5 kg of DIAION HP 20 (Mitsubishi Chem. Corp., Japan) and eluted with 20%, 50%, and 80%, MeOH solutions, successively. Among the fractions tested, the fraction eluted with 50% MeOH exhibited the strongest inhibitory effect on the platelet aggregation induced by collagen. Then, the fraction was concentrated under reduced pressure and yielded a residue (2.93 g). The residue was redissolved in 50% MeOH and filtered, and then subjected to HPLC, and each of the peaks on the chromatogram was collected repeatedly. The system is as follows: HPLC system/pump, LC-10ATvp (Shimadzu, Japan); detector, SPD-10Avp (Shimadzu) at 260 nm; column, RPAQUEOUS 
RESULTS AND DISCUSSION
To isolate an antiplatelet aggregating constituent from the leaves of C. alata, we encountered difficulty in selecting a suitable HPLC column and eluent due to its high solubility in acid solutions. Attempting various columns, observing the short retention times of the constituent, we selected to use a triacontylsilyl silica (C 30 ) column because the stationary phase was proven to be tolerable under acid pH conditions. 6) The mobile phase containing 1% diluted AcOH and 1% MeCN afforded a good separation of the constituent peak, as shown in Fig. 2 . As a result, we isolated adenine (1) as an active constituent ( Fig. 1) by preparative HPLC.
The inhibitory effects of adenine on the platelet aggregation induced by collagen (1.0 mg/ml as the final concentration) were studied in comparison with those of adenosine ( Fig. 1) as the positive control. Table 1 exhibits the antiplatelet aggregating effects of adenine and adenosine. Adenosine has been reported as a potent inhibitor of platelet aggregation, 5) showing high inhibitory rates at the concentrations tested (Table 1, Figs. 3D, F) . On the other hand, adenine at 200 mM as the final concentration inhibited the platelet aggregation induced by the aforementioned concentration of collagen, but little inhibitory effect was noted at 20 mM (Table  1) . Although adenine was a weaker platelet aggregating inhibitor than adenosine, adenine at 200 mM as the final concentration controlled the formation of large-sized platelet aggregates from small-sized platelet aggregates, compared with the aggregates induced by collagen in the presence of saline (blank) replacing adenine, as shown in Table 2 . Also, Fig. 3E clearly demonstrated the predominant distribution of smallsized platelet aggregates in comparison with the absence of adenine (Fig. 3B) . The predominant distribution of smallsized platelet aggregates indicates the inhibition of platelet aggregation, as previously reported.
1-3) Furthermore, adenine showed little inhibitory effect on the platelet aggregation induced by ADP (5.0 mM as the final concentration), as shown in Table 1 , Figs. 4B and D, as reflected in the predominant distribution of large-sized platelet aggregates. In contrast, adenosine exhibited potent inhibitory effects on the platelet aggregation induced by ADP (Table 1) , strongly preventing the formation of large-sized platelet aggregates from the small-sized aggregates (Table 3, Figs. 4C, E) .
Adenine is an aminopurine found widely in plant and animal cells as a free base, nucleoside, and nucleotide. 7) In fact, adenine as a free base has been isolated from various medicinal plants, including Euphoria longana, 8) Annora purpurea, 9) and Panax notoginseng; 10) however, no report has mentioned the inhibitory effects of adenine on platelet aggregation, al- though 2-thioadenine derivatives, 11) AMP and ATP, 12) and adenosine analogues 5) were previously studied. From the viewpoint of pharmacological studies, adenine has been previously investigated, such as on red cell preservation 13) and leucopoiesis, 14) whereas no study on the inhibition of platelet aggregation has been performed. Consequently, this is the first finding on the inhibitory effect of adenine on platelet aggregation induced by collagen. We assume one reason leading to the present finding may be the use of a platelet aggregometer employing a laser-scattering method as a more sentitive than conventional methods for measuring platelet aggregation with the use of the optical density (OD) [15] [16] [17] or impedance. [18] [19] [20] Because these methods only count the largesized platelet aggregates and do not provide information on varied sizes of platelet aggregates, our present method using light-scattering intensity (LSI) allows us to determine the platelet aggregate size distribution and the extent of aggregation to be estimated. Moreover, the method using LSI is sensitive to small-sized aggregates such as those formed in platelet aggregation induced by low concentrations of aggre- 
97.3Ϯ1.2 c)
The final concentration of collagen is 1.0 mg/ml. a-c) Statistical significance of difference at pϽ0.05 when compared with saline by Bonferroni's multiple t-test. nϭ3, ϮS.E.M. gating agents, including collagen. Although the inhibitory mechanism of adenine is yet to be elucidated, our findings confirmed that adenine more strongly inhibited platelet aggregation induced by collagen than by ADP (Table 1) . On the other hand, adenosine inhibited platelet aggregation induced both by collagen and ADP, confirming the inhibitory action of adenosine is not specific for ADP, as previously reported, 21) which is also supported in the present study (Table  1) . Also, Figs. 4C and E indicate the predominant distribution of small-sized platelet aggregates, with little of the large-sized platelet aggregates.
We therefore attempted to compare the action of adenine on platelet aggregation with the already proposed action of adenosine. It is suggested that adenosine acts at a receptor on the platelet membrane, A 2A , to activate adenylate cyclase, 22, 23) and that the antiplatelet aggregatory activity of adenosine depends on the inhibition of both calcium influx and the mobilization of internal stores, coupled with adenylate cyclase stimulation. 24) Also, it has been proposed that it is the balance between the cAMP lowering activity of thromboxane A 2 and cAMP that stimulates properties of prostaglandin I 2 (PGI 2 ), which regulates platelet aggregation. 25, 26) Because of the structural similarities of adenine and adenosine, we speculate that adenine may bind in a non-specific manner to the adenosine receptor with a low affinity, while it binds unlikely to ADP receptors, even in a non-specific manner, because of a weak inhibitory effect of adenine on the platelet aggregation induced by ADP, as shown in Table 1 . It is also possible that a high concentration of adenine may affect the balance of nucleoside or nucleotide in the plasma in a manner comparable to AMP, 27) resulting in the accumulation of nucleoside, nucleotide, or adenine analogues possessing inhibitory effects on platelet aggregation. Moreover, it is of interest to evaluate the role of adenine in respect to platelet aggregation in the presence of other nucleosides and nucleotides interacting with the well-studied receptors on the platelet membrane, 21) coupled with the measurement of enzymatic activities involved in platelet aggregation.
In conclusion, adenine isolated from the leaves of C. alata was found to be an inhibitor of platelet aggregation induced by collagen, although its inhibitory potency is weaker than adenosine. Furthermore, adenine had little inhibitory effect on the platelet aggregation induced by ADP. A platelet aggregometer employing a laser-scattering method enabled us to find the inhibitory effect of adenine that was never reported previously because of the sensitivity of the present method over conventional methods, providing us with additional information on the size distribution of platelet aggregates, particularly of the small-sized platelet aggregates.
